This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

Weaker transcription factors are better when they work together

Weaker transcription factors are better when they work together
Bioengineers can control cell behavior with artificial gene circuits, but it has proven difficult to design specialized proteins called transcription factors (TF) that can activate synthetic genes without occasionally activating some naturally occurring genes. Rice University bioengineer Caleb Bashor co-led the development of a generalizable method engineers can use to avoid “off-target” gene activation by creating transcription factors that bind weakly with DNA when they are alone and strongly (top right) when they cooperatively assemble (center) with other transcription factors. In experiments, the researchers showed cooperative assembly could improve the long-term stability of synthetic gene circuits (bottom right) by eliminating ill effects of off-target binding (bottom left). Credit: Caleb Bashor/Rice University

Bioengineers can tailor the genomes of cells to create "cellular therapies" that fight disease, but they have found it difficult to design specialized activating proteins called transcription factors that can throw the switch on bioengineered genes without occasionally turning on some of the cell's naturally occurring genes.

In a study published online in Cell, bioengineers from Rice University, Boston University, Harvard Medical School, Dartmouth College and Harvard University's Wyss Institute showed they could all but eliminate such "off-target" gene activations using a method that takes its cue from nature.

"We made our weaker," said co-senior author Caleb Bashor, an assistant professor of both bioengineering and biosciences at Rice who helped lead the study. "Because they bind more weakly overall, the chances of their binding off-target drop to almost nothing."

In general, bioengineers have leaned toward designing strong-binding transcription factors to help ensure get activated when they are supposed to. While weakening transcription factors seems counterintuitive, Bashor's research group has collaborated with the group of BU's Ahmad "Mo" Khalil for years to build and test tools that employ weaker transcription factors by making them work in teams.

"Transcription factors act as the 'wiring' in gene circuits by linking together the expression of different in the circuit," Bashor said.

Gene circuits are sets of genes that work together to perform a specific function. For example, in previous work Bashor and colleagues implemented circuits that performed programmable Boolean logic, , analog-to-digital conversion and other .

Each transcription factor activates its specific target gene by binding with a particular sequence of DNA that activates that gene. Bioengineers can use one transcription factor to turn a particular element of a gene circuit on, for example, another to turn its output from low to high and yet another to turn it off.

To ensure that their weakened transcription factors activated their target genes when called upon, Bashor, Khalil and colleagues employed a phenomenon called cooperative assembly. In their , a transcription factor only activates its target by first merging with one or more other factors to form a large protein complex. The assembled complex, behaving as a single unit, activates the target gene.

"Our design makes them strong as a group, but weak alone," Bashor said. "It ensures that the only genes they can get together to activate are the ones in the circuit. The result of this is gene circuits that work normally, but are also 'stabilized' and remain in the cell long-term."

Bashor said nature's use of a similar strategy in humans and in other complex life was an inspiration for the project.

To illustrate the work's potential, he used the example of cell-based therapies. In many, the number of engineered cells a patient receives is far fewer than the number needed to produce a therapeutic effect. Meaning, the treatment is only effective if the engineered cells thrive, reproduce and grow into a population that's large enough to take on the disease.

"Any burden imposed through off-target interactions lowers the odds of success," he said. "Our approach offers a generalizable set of rules engineers can use to insulate gene circuits from the and mitigate off-target burdens."

More information: Meghan D.J. Bragdon et al, Cooperative assembly confers regulatory specificity and long-term genetic circuit stability, Cell (2023). DOI: 10.1016/j.cell.2023.07.012

Journal information: Cell

Provided by Rice University

Citation: Weaker transcription factors are better when they work together (2023, August 14) retrieved 25 February 2024 from https://phys.org/news/2023-08-weaker-transcription-factors.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

It takes three to tango: Study reveals transcription factors bind DNA, protein and RNA

1 shares

Feedback to editors